• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak.

作者信息

Mahalmani Vidya, Kumaravel J, Jain Manav, Prakash Ajay, Medhi Bikash

机构信息

Department of Pharmacology, Jawaharlal Nehru Medical College, KAHER, Belgaum, Karnataka, India.

Department of Pharmacology, PGIMER, Chandigarh, India.

出版信息

Indian J Pharmacol. 2021 May-Jun;53(3):187-191. doi: 10.4103/ijp.ijp_430_21.

DOI:10.4103/ijp.ijp_430_21
PMID:34169902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8262419/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1d7/8262419/271bd3ca1fea/IJPharm-53-187-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1d7/8262419/271bd3ca1fea/IJPharm-53-187-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1d7/8262419/271bd3ca1fea/IJPharm-53-187-g001.jpg

相似文献

1
Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak.抗微生物药物耐药性：在新冠疫情背后潜伏的无形威胁。
Indian J Pharmacol. 2021 May-Jun;53(3):187-191. doi: 10.4103/ijp.ijp_430_21.
2
Role of pharmacists in antimicrobial stewardship programmes.药剂师在抗菌药物管理计划中的作用。
Int J Clin Pharm. 2018 Oct;40(5):948-952. doi: 10.1007/s11096-018-0675-z. Epub 2018 Sep 22.
3
Analysis of the impact of antimicrobial management and rational use of antibiotics.抗菌药物管理与合理应用的影响分析。
Eur J Hosp Pharm. 2020 Sep;27(5):286-291. doi: 10.1136/ejhpharm-2018-001609. Epub 2019 Jan 19.
4
Antimicrobial resistance and COVID-19: Intersections and implications.抗微生物药物耐药性与 COVID-19：交叉与影响。
Elife. 2021 Feb 16;10:e64139. doi: 10.7554/eLife.64139.
5
Pediatric antimicrobial stewardship in the COVID-19 outbreak.COVID-19疫情期间的儿科抗菌药物管理
Infect Control Hosp Epidemiol. 2021 May;42(5):642-644. doi: 10.1017/ice.2020.312. Epub 2020 Jun 24.
6
Antibiotic overconsumption and resistance in Turkey.土耳其的抗生素过度使用与耐药性
Clin Microbiol Infect. 2019 Jun;25(6):651-653. doi: 10.1016/j.cmi.2019.02.024. Epub 2019 Mar 4.
7
Tackling antimicrobial resistance needs a tailored approach - four specialists weigh in.应对抗菌素耐药性需要一种量身定制的方法——四位专家阐述了各自的观点。
Nature. 2024 Sep;633(8030):521-524. doi: 10.1038/d41586-024-02971-9.
8
Combating resistance while maintaining innovation: the future of antimicrobial stewardship.在保持创新的同时对抗耐药性：抗菌药物管理的未来。
Future Microbiol. 2019 Oct;14:1331-1341. doi: 10.2217/fmb-2019-0227. Epub 2019 Sep 17.
9
COVID-19 and antimicrobial stewardship: What is the interplay?新型冠状病毒肺炎与抗菌药物管理：二者有何相互作用？
Infect Control Hosp Epidemiol. 2021 Mar;42(3):378-379. doi: 10.1017/ice.2020.246. Epub 2020 May 15.
10
Prioritizing a One Health Approach in the Immediate Fight Against Antimicrobial Resistance.优先采取一种大健康方法，立即应对抗微生物药物耐药性。
Ecohealth. 2019 Sep;16(3):410-413. doi: 10.1007/s10393-018-1325-6. Epub 2018 Mar 9.

本文引用的文献

1
Bacterial Coinfections in Coronavirus Disease 2019.2019 年冠状病毒病中的细菌合并感染。
Trends Microbiol. 2021 Oct;29(10):930-941. doi: 10.1016/j.tim.2021.03.018. Epub 2021 Apr 8.
2
Risk factors for bacterial infections in patients with moderate to severe COVID-19: A case-control study.中重度 COVID-19 患者细菌感染的危险因素：一项病例对照研究。
J Med Virol. 2021 Jul;93(7):4564-4569. doi: 10.1002/jmv.27000. Epub 2021 Apr 15.
3
High rates of antibiotic prescriptions in children with COVID-19 or multisystem inflammatory syndrome: A multinational experience in 990 cases from Latin America.
高比例抗生素处方用于治疗 COVID-19 或儿童多系统炎症综合征：拉丁美洲 990 例多国经验。
Acta Paediatr. 2021 Jun;110(6):1902-1910. doi: 10.1111/apa.15847. Epub 2021 Mar 26.
4
Ventilator-associated pneumonia in critically ill patients with COVID-19.COVID-19 重症患者呼吸机相关性肺炎。
Crit Care. 2021 Jan 11;25(1):25. doi: 10.1186/s13054-021-03460-5.
5
Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia.患有重症肺炎的危重型COVID-19患者的细菌合并感染
Infection. 2021 Jun;49(3):559-562. doi: 10.1007/s15010-020-01553-x. Epub 2021 Jan 3.
6
Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome.与 COVID-19 相关的医院感染：重症监护病房的临床特征和结局。
Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):495-502. doi: 10.1007/s10096-020-04142-w. Epub 2021 Jan 3.
7
Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study.预测 COVID-19 患者医院获得性细菌和真菌感染的因素：一项前瞻性观察研究。
J Antimicrob Chemother. 2021 Mar 12;76(4):1078-1084. doi: 10.1093/jac/dkaa530.
8
Analysis of the Risk Factors for Nosocomial Bacterial Infection in Patients with COVID-19 in a Tertiary Hospital.某三级医院新冠肺炎患者医院内细菌感染危险因素分析
Risk Manag Healthc Policy. 2020 Nov 13;13:2593-2599. doi: 10.2147/RMHP.S277963. eCollection 2020.
9
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors.COVID-19 住院患者的继发感染：发生率和预测因素。
Clin Microbiol Infect. 2021 Mar;27(3):451-457. doi: 10.1016/j.cmi.2020.10.021. Epub 2020 Oct 24.
10
Predictors and outcomes of healthcare-associated infections in COVID-19 patients.预测 COVID-19 患者发生医院获得性感染的因素和结果。
Int J Infect Dis. 2021 Mar;104:287-292. doi: 10.1016/j.ijid.2020.11.135. Epub 2020 Nov 15.